Kai-Xin-San ameliorates Alzheimer's disease-related neuropathology and cognitive impairment in APP/PS1 mice via the mitochondrial autophagy-NLRP3 inflammasome pathway
Journal of Ethnopharmacology · 2024
DOI: 10.1016/j.jep.2024.118145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2024. Verfasst von Xiaoxiao Shan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, School of Pharmacy, Anhui University of Chinese Medicine, Hef…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Alzheimer Disease, Mitochondria, Cognitive Dysfunction. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Anhui Provincial Key Research and Development Plan, National Natural Science Foundation of China, Natural Science Foundation of Anhui Province.
Themen: Demenz
Abstract (Originalsprache)
ETHNOPHARMACOLOGICAL RELEVANCE: Kai-Xin-San (KXS) is a classic famous prescription that has been utilized for centuries to address dementia. New investigations have shown that the anti-dementia effect of KXS is connected with improved neuroinflammation. Nevertheless, the underlying mechanism is not well elucidated. AIM OF THE STUDY: We propose to discover the ameliorative impact of KXS on Alzheimer's disease (AD) and its regulatory role on the mitochondrial autophagy-nod-like receptor protein 3 (NLRP3) inflammasome pathway. MATERIALS AND METHODS: The Y maze, Morris water maze, and new objection recognition tests were applied to ascertain the spatial learning and memory capacities of amyloid precursor protein/presenilin 1 (APP/PS1) mice after KXS-treatment. Meanwhile, the biochemical indexes of the hippocampus were detected by reagent kits. The pathological alterations and mitochondrial autophagy in the mice' hippocampus were detected utilizing hematoxylin and eosin (H&E), immunohistochemistry, immunofluorescence staining, and transmission electron microscopy. Besides, the PTEN-induced putative kinase 1 (PINK1)/Parkin and NLRP3 inflammasome pathways protein expressions were determined employing the immunoblot analysis. RESULTS: The results of behavioral tests showed that KXS significantly enhanced the AD mice' spatial learning and memory capacities. Furthermore, KXS reversed the biochemical index levels and reduced amyloid-β protein deposition in AD mice brains. Besides, H&E staining showed that KXS remarkably ameliorated the neuronal damage in AD mice. Concurrently, the results of transmission electron microscopy suggest that KXS ameliorated the mitochondrial damage in microglia and promoted mitochondrial autophagy. Moreover, the immunofluorescence outcomes exhibited that KXS promoted the expression of protein 1 light chain 3B (LC3B) associated with microtubule and the generation of autophagic flux. Notably, the immunofluorescence co-localization results confirmed the presence of mitochondrial autophagy in microglia. Finally, KXS promoted the protein expressions of the PINK1/Parkin pathway and reduced the activation of NLRP3 inflammasome. Most importantly, these beneficial effects of KXS were attenuated by the mitochondrial autophagy inhibitor chloroquine. CONCLUSION: KXS ameliorates AD-related neuropathology and cognitive impairment in APP/PS1 mice by enhancing the mitochondrial autophagy and suppressing the NLRP3 inflammasome pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China; Center for Xin'an Medicine and Modernization of Tra…
- Hefei Innovation Pharmaceutical Technology Co.ltd., Hefei, 230031, China. Electronic address: 364190941@qq.com.
- Hefei Innovation Pharmaceutical Technology Co.ltd., Hefei, 230031, China. Electronic address: 1151095184@qq.com.
Förderung
- Anhui Provincial Key Research and Development Plan
- National Natural Science Foundation of China
- Natural Science Foundation of Anhui Province
Zitieren
APA
Shan, X., Tao, W., Li, J., Tao, W., Li, D., Zhou, L., Yang, X., Dong, C., Huang, S., Chu, X., & Zhang, C. (2024). Kai-Xin-San ameliorates Alzheimer's disease-related neuropathology and cognitive impairment in APP/PS1 mice via the mitochondrial autophagy-NLRP3 inflammasome pathway. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2024.118145
Vancouver
Shan X, Tao W, Li J, Tao W, Li D, Zhou L, et al. Kai-Xin-San ameliorates Alzheimer's disease-related neuropathology and cognitive impairment in APP/PS1 mice via the mitochondrial autophagy-NLRP3 inflammasome pathway. Journal of Ethnopharmacology. 2024. doi:10.1016/j.jep.2024.118145
BibTeX
@article{Shan2024,
author = {Shan, Xiaoxiao and Tao, Wenwen and Li, Junying and Tao, Wenkang and Li, Dawei and Zhou, Lele and Yang, Xuan and Dong, Chong and Huang, Shunwang and Chu, Xiaoqin and Zhang, Caiyun},
title = {Kai-Xin-San ameliorates Alzheimer's disease-related neuropathology and cognitive impairment in APP/PS1 mice via the mitochondrial autophagy-NLRP3 inflammasome pathway},
journal = {Journal of Ethnopharmacology},
year = {2024},
doi = {10.1016/j.jep.2024.118145}
}
EUVIMED